))
EyeCan Season 4, Episode 2 - Age-related Macular Degeneration, with guest Dr. Ravi Dookeran
Manage episode 390262220 series 2999307
Content provided by Canadian Ophthalmological Society. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Canadian Ophthalmological Society or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Welcome to Season 4, Episode 2 of The EyeCan Podcast! Our topic on today’s episode of EyeCan is Age-related Macular Degeneration, with guest Ravi Dookeran of Winnipeg, Manitoba.
Dr. Dookeran has worked in Winnipeg since 2006 in the University of Manitoba department of Ophthalmology. He is the medical director of the Waterfront Eye Institute and runs a surgical and medical Retinal practice serving all of Manitoba, Nunavut and western Ontario. After completing his ophthalmology residency at the University of Alberta, Dr. Dookeran went on to complete a 2-year surgical and medical Retina fellowship at McGill University. He is affiliated with the University of Manitoba's Department of Ophthalmology as an Assistant Professor, teaching residents and retina fellows and is actively involved in clinical research having authored numerous publications.
Dr. Dookeran has been actively involved in developing a tele-ophthalmology program and serves as the medical director of the Manitoba Retinal Screening and Vision Program (MRSVP) providing access to care for diabetic patients in northern and remote communities across Manitoba.
In addition to being vice president of the Eye Physicians and Surgeons of Manitoba for many years, he sat on the COS board of directors as Treasurer from 2019 to 2022 and continues to be involved in the COS Foundation.
With your hosts, Dr. Mona Daghar and Dr. Hady Saheb.
Written and directed by Kim Tytler.
Produced by John Allaire of Allaire Strategic Works.
The EyeCan Podcast is made possible by support from Bayer.
Show notes:
Early Treatment Diabetic Retinopathy Study– ( https://pubmed.ncbi.nlm.nih.gov/2062510/ ) the landmark study that still guides how we treat diabetics today.
See the Possibilities Eye Health page on AMD ( https://www.seethepossibilities.ca/eye-health/age-related-macular-degeneration/ )
Learn more about the COS Council in Advocacy ( https://www.cos-sco.ca/council-on-advocacy/ )
Comments about EyeCan? Contact [email protected] and we’ll get back to you soon!
54 episodes
Share
